Clinical and Molecular Epidemiology of Cancer

Research group

Group Leader

Miquel Porta Serra

We conduct integrative scientific research on human pancreatic cancer at all causal and mechanistic levels, from genomics to clinical medicine to the social and physical environment. Our aim is to achieve an optimal integration of professional cultures, scientific knowledge, methodologies and techniques from epidemiology and public health, clinical medicine and the biological sciences. We are a team that has worked across disciplines for more than three decades, one of the pioneer groups in Europe on clinical and molecular epidemiology. Cancer is a complex set of processes that result from the accumulation of genetic, epigenetic and other alterations during the lifecourse. Thus, integrative studies on the causes of cancer are a natural meeting point between molecular biology and epidemiology. We are also a world-recognized research group on the biomonitoring of internal body concentrations of environmental chemical agents ("internal contamination") in representative samples of the general population.





Immaculada Collet Diví (Technician)

Marc Domínguez Herrera (Technician)

Magda Gasull Panadès (Technician)

José Antonio Pumarega Rodríguez (Technician)

Yolanda Rovira Pons (Research Assistant)


Main Publications

• NCD Risk Factor Collaboration (NCD-RisC) (...Elosua R, Gasull M, Marrugat J, Porta M...). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 2017; 389: 37-55. IF 47.831. D1.

• NCD Risk Factor Collaboration (NCD-RisC) (...Gasull M, Marrugat J, Porta M...). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 2017; 390: 2627-2642. IF 47.831. D1.

• Fernández MF, Pumarega J, Porta M, Molina-Molina JM, Arrebola JP, Olea N. Changes in the total effective xenoestrogen burden (TEXB) of breast cancer patients during an 18-month post-surgical follow-up. Reproduct Toxicol 2017; 69: 212-220. IF 2.341. Q2.

• Pumarega J, Larrea C, Muñoz A, Pallarès N, Gasull M, Rodríguez G, Jariod M, Porta M. Citizens' perceptions of the presence and health risks of synthetic chemicals in food: results of an online survey in Spain. Gac Sanit 2017; 31: 371-381. IF 1.768. Q2.

Ongoing Research Projects

• Plasma concentrations of organochlorine compounds and lifestyle factors pancreatic cancer risk within the EPIC cohort

- Fundació La Marató de TV3 (20132910)

- From 2014 to 2017

- Principal investigator: Porta Serra, Miquel

• Concentraciones sanguíneas de compuestos organoclorados, estilo de vida y riesgo de cáncer de páncreas en la cohorte EPIC

- Fondo de Investigación Sanitaria. ISCIII (PI13/00020)

- From 2014 to 2017

- Principal investigator: Porta Serra, Miquel


Participation in Research Networks

• CIBERESP: Epidemiología y salud pública

- Fondo de Investigación Sanitaria. ISCIII (CB06/02/0034)

- Principal investigator: Porta Serra, Miquel


Group’s Recognitions

• Members of the Group have acted as Advisors and External Reviewers to the World Health Organization (Avoding early environmental exposures); CaixaBank (Postgraduate Fellowships); Environment and Health Fund, Israel; Cancer TMOI of the French National Alliance for Life and Health Sciences (AVIESAN) & French National Cancer Institute (INCa); National Science Centre (Narodowe Centrum Nauki - NCN), Poland; Kuwait University; Escola de Salut Pública de Menorca; DEMCat (TermCat and Acadèmia de Ciències Mèdiques i de la Salut de Catalunya i Balears). They have also been invited to give keynote lectures and seminars at Columbia University, Mailman School of Public Health, New York; Columbia University, Center for Environmental Health in Northern Manhattan, New York; City University of New York (CUNY), Center for the Biology of Natural Systems (CBNS), Queens College, New York; CUNY School of Public Health; Johns Hopkins University, Bloomberg School of Public Health, Baltimore; Kuwait University, Faculty of Medicine; University of Ottawa, School of Epidemiology, Public Health and Preventive Medicine, Ottawa; University of Bergen, Department of Global Health and Primary Care, National Research School in Population Based Epidemiology; Universidad Miguel Hernández, Public Health PhD Programme; Pompeu Fabra University and Autonomous University of Barcelona, University Master’s degree in Public Health.

• Officially recognised as a consolidated research group by the Generalitat de Catalunya: Grup de Recerca en Epidemiologia Clínica i Molecular del Càncer (2017-2019)

- Agència de Gestió d’Ajuts Universitaris i de Recerca (SGR 439)

- Principal investigator: Porta Serra, Miquel



C/ Doctor Aiguader, 88

08003 Barcelona

(+34) 93 316 04 00